Home The Word Brain	My Amedeo FAQ Privacy About
	Hanzi Hunter Learning 500 Chinese characters in 30 days is possible. Abstract • About

Malignant Melanoma

Free Subscription 13.04.2026 2 Am J Dermatopathol 2 Ann Surg Oncol 1 Br J Cancer 1 Clin Cancer Res 1 J Am Acad Dermatol 1 J Invest Dermatol 2 Melanoma Res

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

Am J Dermatopathol

1. DARUISH M, Ibrahim H
   Malignant Melanoma With Rhabdomyosarcomatous Differentiation: Report of 2 New Cases.
   Am J Dermatopathol. 2026 Apr 8. doi: 10.1097/DAD.0000000000003292.
   PubMed         Abstract available
   
   
2. LEIBING T, Schweinsberg V, Franklin C, Hitchcock MG MBCHB, MBA, et al
   Rare Presentation of an NF2-Mutated Desmoplastic Melanoma With Pure Spindle Cell Morphology in a 69-Year-Old Patient.
   Am J Dermatopathol. 2026 Apr 6. doi: 10.1097/DAD.0000000000003283.
   PubMed        
   
   

   
   Ann Surg Oncol

3. YEE P, Shen C, Jeun C, Mayhew M, et al
   ASO Visual Abstract: Sentinel Lymph Node Biopsy for Desmoplastic Melanoma: A Systematic Review and Meta-analysis.
   Ann Surg Oncol. 2026 Apr 7. doi: 10.1245/s10434-026-19611.
   PubMed        
   
   
4. RANJBARIAN T, Sharma AK, Turner M, Bouvet M, et al
   Comparison of Indocyanine Green Versus Isosulfan Blue in Melanoma Sentinel Node Biopsy.
   Ann Surg Oncol. 2026 Apr 5. doi: 10.1245/s10434-026-19549.
   PubMed         Abstract available
   
   

   
   Br J Cancer

5. LINDNER ES, Admard J, Demidov G, Armeanu-Ebinger S, et al
   Genetic landscape of stage II melanoma identifies CBL as a new driver gene and prognostic biomarker.
   Br J Cancer. 2026 Apr 9. doi: 10.1038/s41416-026-03394.
   PubMed         Abstract available
   
   

   
   Clin Cancer Res

6. GARRALDA E, Markert C, Moreno V, Calvo E, et al
   A first-in-human phase 1 clinical trial evaluating clinical activity and proof-of-mechanism of tobemstomig, a PD1-LAG3 bispecific antibody, in patients with CPI-experienced melanoma.
   Clin Cancer Res. 2026 Apr 7. doi: 10.1158/1078-0432.CCR-25-4478.
   PubMed         Abstract available
   
   

   
   J Am Acad Dermatol

7. SHAIKH UR, Richter CG, Raj LK, Kapoor D, et al
   Perioperative Racial Disparities in Patients with Acral Lentiginous Melanoma Undergoing Mohs Micrographic Surgery: A Single-Institution Retrospective Cohort Study.
   J Am Acad Dermatol. 2026 Mar 31:S0190-9622(26)00507.
   PubMed        
   
   

   
   J Invest Dermatol

8. YOULDEN DR, Atkinson V, Pinkham MB, Barbour A, et al
   Second primary invasive cutaneous melanomas in Queensland over 4 decades.
   J Invest Dermatol. 2026 Apr 7:S0022-202X(26)00075.
   PubMed         Abstract available
   
   

   
   Melanoma Res

9. PAYSANO MLBA, Kreuz M, Rebelo TG, Talah BAD, et al
   Melanoma risk following fertility treatment in infertile women: a systematic review and meta-analysis.
   Melanoma Res. 2026 Apr 8. doi: 10.1097/CMR.0000000000001090.
   PubMed         Abstract available
   
   
10. IVANOVA M, Stojkovski I, Klisarovska V
    Rapid hyperacute intracranial deterioration following initiation of ipilimumab/nivolumab in BRAF V600E-mutant melanoma of unknown primary with brain metastases after BRAF/MEK inhibitor therapy: a case series.
    Melanoma Res. 2026 Apr 3. doi: 10.1097/CMR.0000000000001098.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Malignant Melanoma is free of charge. Privacy / Datenschutzerklärung | Imprint / Impressum